Additionally, phloridzin targets the PI3K/AKT/mTOR pathway, a key driver of glioblastoma progression, by suppressing PI3K, p‐AKT, and p‐mTOR expression, ultimately decreasing tumor cell survival. This evidence concerns the gene AKT1 and glioblastoma.